Abraxas 1, BRCA1 A Complex Subunit (ABRAXAS1) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Abraxas 1, BRCA1 A Complex Subunit (ABRAXAS1) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAbraxas 1, BRCA1 A Complex Subunit (ABRAXAS1)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formatantigen affinity purified
Size100 µl,
Concentrationn/a
ApplicationsELISA, WB, IHC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionFamily With Sequence Similarity 175, Member A antibody is a Rabbit polyclonal antibody against Family With Sequence Similarity 175, Member A.
ImmunogenHuman FAM175A.
Other Namesfamily with sequence similarity 175, member A, FAM175A, ABRA1, CCDC98, FLJ11520, FLJ12642, FLJ13614, family with sequence similarity 175, family with sequence similarity 175, family with sequence similarity 175 , family with sequence similarity 175 , member A, member A, member A , member A , FAM175A, FAM175A, FAM175A , FAM175A , ABRA1, ABRA1, ABRA1 , ABRA1 , CCDC98, CCDC98, CCDC98 , CCDC98 , FLJ11520, FLJ11520, FLJ11520 , FLJ11520 , FLJ12642, FLJ12642, FLJ12642 , FLJ12642 , FLJ13614, FLJ13614, FLJ13614 , FLJ13614
Gene, Accession #ABRAXAS1, Gene ID: 84142, NCBI: NP_001332891.1, NM_001345962.1, NP_620775.2, NM_139076.2, UniProt: Q6UWZ7
Catalog #abx112438
Priceplease inquire
Order / More InfoAbraxas 1, BRCA1 A Complex Subunit (ABRAXAS1) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.